Condition

Lung Neoplasms clinical trials and research

• 37Clinical trials
• 2New in 30 days
• 24Countries

Newest Lung Neoplasms clinical trials

All recruiting trials (37)

• AI-assisted longitudinal CT to guide indeterminate lung nodules

  This trial tests whether giving doctors an AI report that tracks nodules over serial CT scans helps reduce unnecessary benign lung resections in patients with indeterminate nodules.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07895277

• MRD-guided postoperative monitoring and adaptive treatment for resectable NSCLC

  This study tests a personalized follow-up and treatment plan using ctDNA MRD testing and pathology to guide adjuvant therapy after surgery for stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07894458

• Telerehabilitation exercise program after lung cancer surgery

  A remote rehabilitation program with guided exercises is tested to help adults after lung cancer surgery recover better.

  Recruiting University of Seville · Seville, Andalusia · NCT07861282

• Impact of Exercise on Tumor Immunity in NSCLC Patients Receiving Neoadjuvant Chemo-Immunotherapy

  A structured exercise program is being tested to see if it boosts immune cells in the tumor for patients with resectable NSCLC undergoing pre-surgery chemo-immunotherapy.

  Recruiting at 2 sites Centre Leon Berard · Lyon, Rhône and 1 other locations · NCT07786909

• Low-Dose CT Lung Cancer Screening in Kuwait: Feasibility and Uptake

  This pilot tests whether offering low-dose CT lung cancer screening to high-risk adults in Kuwait is workable and acceptable, with about 500 participants completing a baseline scan.

  Recruiting Chest Diseases Hospital, Ministry of Health, Kuwait · Kuwait City · NCT07766538

• Nitride-based Raman biochip for lung cancer diagnosis and monitoring

  A large observational study in Taiwan will test whether a blood-based nitride-based Raman biochip can help diagnose lung cancer and monitor patients over time.

  Recruiting Taichung Veterans General Hospital · Taichung · NCT07755020

• Modified Arm Positioning to Reduce Shoulder Pain After Thoracoscopic Lobectomy

  This trial tests whether changing how the arm is positioned during thoracoscopic lobectomy can lower shoulder pain on the operated side in adults with lung lesions.

  Recruiting Chengdu Jinjiang Maternity and Child Health Hospital · Chengdu, Sichuan · NCT07746323

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

• Benchmarking AI language models against tumor boards for oncology treatment decisions

  This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.

  Recruiting Assistance Publique - Hôpitaux de Paris · Boulogne-Billancourt and 4 other locations · NCT07739121

• Empowering patients to get lung cancer screening with support and navigation

  This pilot study tests a patient navigation and education program to see if it helps adults who are eligible start and complete low-dose CT lung cancer screening.

  Recruiting at 13 sites University of California, Irvine · Anaheim, California and 56 other locations · NCT07711691

• Multidisciplinary treatment planning for older people with lung cancer

  We will test a team-based approach that uses geriatric assessments to create personalized treatment plans for people aged 60–90 with newly diagnosed lung cancer to see if it improves 3-year progression-free survival compared with past patients.

  Recruiting West China Hospital · Chengdu, Sichuan · NCT07509333

• PF-08634404 Alone or with chemotherapy in early-stage or locally advanced NSCLC

  This study tests PF-08634404 by itself or with chemotherapy in adults with early-stage or locally advanced non-small cell lung cancer that may be surgically removable or were candidates for additional therapy after initial treatment.

  Recruiting at 28 sites Phase 2 Pfizer · Huntsville, Alabama and 36 other locations · NCT07489066

• PF-08634404 with or without chemotherapy for adults with transformed small cell lung cancer

  This will try the experimental drug PF-08634404 by itself and together with chemotherapy in adults whose EGFR-mutated non-small cell lung cancer has turned into transformed small cell lung cancer.

  Recruiting at 55 sites Phase 2 Pfizer · Duarte, California and 60 other locations · NCT07476287

• 3-D virtual resection to predict lung function after VATS anatomical lung surgery

  The study will test whether a 3-D virtual resection from thin-slice CT scans can better predict lung function after VATS lobectomy or segmentectomy for people with non-small cell lung cancer.

  Recruiting National Taiwan University Hospital · Taipei · NCT07436598

• Liquid biopsy pre-screen to reduce unnecessary low-dose CT for high-risk lung cancer

  This will test a blood-based liquid biopsy to see if it can identify high-risk people who can safely skip or delay a low-dose CT scan for lung cancer.

  Recruiting National University Hospital, Singapore · Singapore · NCT07358715

• Multi-omics blood and CT monitoring for early detection of lung cancer recurrence after neoadjuvant therapy and surgery

  This project tests whether combining blood-based multi-omics (metabolomics and cfDNA), CT radiomics, and AI can noninvasively detect early recurrence after surgery in NSCLC patients treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07291921

• Telehealth coaching to support lung cancer screening decisions for Hispanic adults

  This project will test a culturally adapted telehealth decision-coaching and navigation program delivered by bilingual navigators to help Hispanic adults at high risk decide about and access low-dose CT lung cancer screening.

  Recruiting Rutgers, The State University of New Jersey · New Brunswick, New Jersey · NCT07165691

• ALG Lung Cancer Registry (SAFRO2202)

  This registry will collect medical information from adults in Algeria who have been diagnosed with any type of lung cancer to see patterns in diagnosis, treatment, and outcomes.

  Recruiting at 21 sites Société Algérienne de Formation et de Recherche en Oncologie · Algiers, Algiers Province and 20 other locations · NCT07161882

• LUNG-ROLL: Treatment patterns and costs for people with lung cancer in Canada

  This project looks at past health records to see how lung cancer is treated and what healthcare it uses for adults in Alberta and Ontario.

  Recruiting at 2 sites AstraZeneca · Calgary, Alberta and 1 other locations · NCT07143110

• First-line treatment choices and patient profiles in advanced non-small cell lung cancer

  This project will collect electronic medical record data from adults with advanced non‑small cell lung cancer starting first‑line treatment to see if real‑world care and biomarker use (like driver mutations and PD‑L1) match guideline recommendations.

  Recruiting at 2 sites AstraZeneca · Recife and 6 other locations · NCT07109154

• High-sensitivity blood test to detect and monitor multiple cancers

  This study will test a high-sensitivity blood test that looks for tumor DNA to detect and follow several common cancers in adults with those cancers or people having routine health screenings.

  Recruiting Yonsei University · Seoul · NCT07035587

• Trop2- and EpCAM-targeted PET/CT to help distinguish non-small cell lung cancer

  This project will test whether PET/CT scans that target Trop2 and EpCAM can show protein expression in tumors of people with suspected non-small cell lung cancer.

  Recruiting RenJi Hospital · Shanghai · NCT07026110

• Early intervention strategies for lung cancer detection

  This study is testing if using low-dose CT scans in community health centers can help find lung cancer earlier in people aged 40-75 who don't have a history of the disease.

  Recruiting The First Affiliated Hospital of Guangzhou Medical University · Guangzhou, Guangdong · NCT06988943

• Preventing Dato‑DXd–related mouth sores with dexamethasone mouthwash

  This study will see if using an alcohol‑free dexamethasone mouthwash can prevent mouth sores in adults with advanced breast cancer or non‑squamous non‑small cell lung cancer who are receiving datopotumab deruxtecan.

  Recruiting Phase 2 Brown University · Providence, Rhode Island · NCT06974604

• Anti-mesothelin TNhYP218 CAR T cell therapy for mesothelin-expressing solid tumors

  This treatment will test whether a person's own engineered CAR T cells that target mesothelin can help adults with mesothelin-expressing solid tumors, including mesothelioma, that have returned or spread after standard therapy.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06885697

• Teniposide after prior therapy for c-Myc–driven extensive-stage small cell lung cancer

  This will try teniposide in people with extensive-stage small cell lung cancer driven by high c-Myc who have progressed after standard treatment.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT06758700

• Exploring the link between psychological distress and treatment outcomes in lung cancer patients

  This study looks at how stress and emotional struggles affect the success of cancer treatments in people with advanced lung cancer.

  Recruiting Shanghai Chest Hospital · Shanghai, Shanghai Municipality · NCT06218901

• Testing JYP0322 for ROS1 Fusion-Positive Solid Tumors

  This study is testing a new oral medication called JYP0322 to see if it can help people with certain types of advanced solid tumors that have a specific genetic change called ROS1 fusion.

  Recruiting Phase 1 Guangzhou JOYO Pharma Co., Ltd · Guangzhou, Guangdong · NCT06128148

• Evaluating HTL0039732 for Advanced Solid Tumours

  This study is testing a new drug called HTL0039732, alone and with another treatment, to see if it can help people with advanced solid tumors by boosting their immune response against cancer.

  Recruiting at 6 sites Phase 1/2 Cancer Research UK · Cambridge and 5 other locations · NCT05944237

• Using high-resolution PET-CT imaging during lung surgery

  This study tests whether using advanced imaging during lung surgery can help doctors see if they've removed all the cancer and make better decisions while operating.

  Recruiting University Hospital, Ghent · Ghent · NCT05693363

• Comparing segmentectomy and lobectomy for small lung tumors

  This study is testing whether a lung surgery called segmentectomy is just as good as a larger surgery called lobectomy for people with small lung tumors to see how it affects their chances of staying cancer-free and living longer.

  Recruiting The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT04944563

• Comparing two surgical approaches for early-stage lung cancer with ground-glass nodules

  This study is testing which of two surgical methods is better for people with early-stage lung cancer that has ground-glass nodules, to see which one helps them live longer and stay cancer-free.

  Recruiting Tianjin Medical University Cancer Institute and Hospital · Tianjin, Tianjin Municipality · NCT04631770

• Mobile low-dose CT screening for lung cancer in younger adults

  This study is testing if a mobile low-dose CT scan can help find lung cancer earlier in younger adults aged 40-54 who have a significant history of smoking.

  Recruiting Wake Forest University Health Sciences · Charlotte, North Carolina · NCT04577599

• Creating a bank of tumor tissue samples for research

  This study is creating a collection of tumor tissue samples from cancer patients and healthy individuals to help researchers find better ways to diagnose and treat cancer.

  Recruiting Medical University of Vienna · Vienna and 2 other locations · NCT01789229

• Creating a tumor bank for blood samples from cancer patients and healthy controls

  This study is collecting blood samples from cancer patients and healthy people to help researchers find better ways to diagnose and treat cancer.

  Recruiting Medical University of Vienna · Innsbruck and 5 other locations · NCT01763125

• Collecting samples from lung cancer patients

  This study is collecting samples from lung cancer patients to help researchers learn more about the disease and find better ways to detect and treat it.

  Recruiting University of Colorado, Denver · Aurora, Colorado · NCT01585675

• Analyzing Oncogenes and Resistance in Lung Cancer

  This study is trying to find out how certain changes in lung cancer tumors affect how well treatments work, so doctors can make better decisions for patients.

  Recruiting University of Colorado, Denver · Aurora, Colorado · NCT01580982

Related topics

Quick answers

How many Lung Neoplasms clinical trials are recruiting right now?

37, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 24 countries. The most sites are in China (14 trials), United States (9 trials), Taiwan (4 trials), France (3 trials), Spain (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →